tiprankstipranks
Trending News
More News >
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
US Market

Chemomab Therapeutics (CMMB) Income Statement

Compare
323 Followers

Chemomab Therapeutics Income Statement

Last quarter (Q3 2025), Chemomab Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Chemomab Therapeutics's net income was $-1.74M. See Chemomab Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -53.25K$ -66.83K$ -57.77K$ -34.02K$ -80.00K
Operating Expenses
$ 14.74M$ 25.46M$ 28.53M$ 12.37M$ 5.97M
Depreciation and Amortization
$ 53.25K$ 67.00K$ 57.77K$ 34.02K$ 24.00K
EBITDA
$ -13.96M$ -25.39M$ -28.48M$ -12.33M$ -5.95M
Operating Income
$ -14.74M$ -25.46M$ -28.53M$ -12.37M$ -5.97M
Other Income/Expenses
$ 794.00K$ 1.24M$ 353.00K$ -111.00K$ 21.00K
Pretax Income
$ -13.95M$ -24.22M$ -28.18M$ -12.48M$ -5.95M
Net Income
$ -13.95M$ -24.22M$ -27.65M$ -12.48M$ -5.95M
Per Share Metrics
Basic EPS
$ -3.12$ -8.22$ -9.68$ -4.80$ -25.21
Diluted EPS
$ -3.12$ -8.22$ -9.68$ -4.80$ -25.21
Weighted Average Shares Outstanding
4.49M 2.94M 2.84M 2.59M 463.74K
Weighted Average Shares Outstanding (Diluted)
4.49M 2.94M 2.84M 2.59M 463.74K
Currency in USD

Chemomab Therapeutics Earnings and Revenue History